MARKET

VIVO

VIVO

Meridian Biosci
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.03
+0.06
+0.86%
After Hours: 7.03 0 0.00% 16:00 03/27 EDT
OPEN
6.77
PREV CLOSE
6.97
HIGH
7.20
LOW
6.57
VOLUME
563.69K
TURNOVER
--
52 WEEK HIGH
17.71
52 WEEK LOW
5.51
MARKET CAP
301.09M
P/E (TTM)
15.79
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of VIVO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average VIVO stock price target is 9.00 with a high estimate of 9.00 and a low estimate of 9.00.

EPS

VIVO News

More
  • Cannabis Stock Gainers And Losers From March 17, 2020
  • Benzinga · 03/17 20:50
  • Meridian Bio offers help to coronavirus test makers
  • Seeking Alpha - Article · 03/16 17:41
  • Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation
  • GlobeNewswire · 03/16 16:51
  • Meridian Bioscience Announces FDA-Clearance for New Curian Analyzer and the Curian HpSA® Assay
  • GlobeNewswire · 03/16 13:00

Industry

Medical Equipment, Supplies & Distribution
-1.60%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About VIVO

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.
More

Webull offers kinds of Meridian Bioscience, Inc. stock information, including NASDAQ:VIVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVO stock news, and many more online research tools to help you make informed decisions.